Hepatitis researchers have long thought that immune cells sent by the body to attack virus-infected cells in the liver cause the acute liver injury associated with HAV and other hepatitis viruses.
"The virus evokes a response in the infected cell that activates a pre-programmed cell death pathway," said Stanley Lemon, professor at University of North Carolina (UNC) at Chapel Hill in the US.
"In effect, the cell commits suicide, sacrificing itself along with the virus in an effort to save the host. This results in inflammation within the liver that we recognise as hepatitis," Lemon added.
Symptoms of hepatitis A include nausea, stomach pain, fever, sore throat, headache and diarrhea. People infected with HAV may not experience any symptoms, but shed the virus for two to four weeks.
Also Read
During this period, an infected person can pass the virus to others. HAV does not cause chronic liver disease like hepatitis B and C viruses. But in rare cases, it can cause acute liver failure, which is often fatal.
For decades, researchers believed only primates - humans, chimpanzees and a few species of monkeys - could be infected by HAV.
However, when the team interrupted the intrinsic cellular antiviral response in mice, they discovered the virus could jump species.
"The ability of the virus to jump into mice is dependent upon knocking out the mouse interferon system, which HAV cannot do on its own," said Lemon.
The research team is now poised to investigate the complicated interplay of nonspecific "innate" and specific "adaptive" immune responses that ultimately control the infection and eliminate HAV from the host - processes that are not well understood for any of the five human hepatitis viruses.
The study appears in the journal Science.
Disclaimer: No Business Standard Journalist was involved in creation of this content